Kai van Hateren
Impact in
- Analytical Chemistry top 2%
- Analytical Methods in Pharmaceuticals
- Analytical chemistry methods development
- Transplantation top 10%
Papers in
-
- Analytical Methods in Pharmaceuticals 18
-
- Antifungal resistance and susceptibility 4
- Tuberculosis Research and Epidemiology 2
- Co-authors
- Jan‐Willem C. Alffenaar (16 shared papers)Ben Greijdanus (7 shared papers)Jos G. W. Kosterink (9 shared papers)Donald R. A. Uges (4 shared papers)Daan Johannes Touw (14 shared papers)Remco A. Koster (5 shared papers)Tjip S. van der Werf (6 shared papers)A. Mireille A. Wessels (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Bioanalysis (3 papers)Journal of Chromatography B (3 papers)Biomedical Chromatography (1 paper)Journal of Chromatography A (1 paper)
- Partner nations
- NetherlandsUnited StatesRussia
In The Last Decade
Kai van Hateren
21 papers receiving 450 citations
Peers
Comparison fields: 5 of 39
- Analytical Chemistry 198
- Transplantation 25
- Immunology 116
- Infectious Diseases 111
- Pharmacology 83
Countries citing papers authored by Kai van Hateren
This map shows the geographic impact of Kai van Hateren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai van Hateren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai van Hateren more than expected).
Fields of papers citing papers by Kai van Hateren
This network shows the impact of papers produced by Kai van Hateren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai van Hateren. The network helps show where Kai van Hateren may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai van Hateren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 94 | |
| 2 | 2013 | 55 | |
| 3 | 2019 | 55 | |
| 4 | 2014 | 40 | |
| 5 | 2017 | 32 | |
| 6 | 2015 | 31 | |
| 7 | 2013 | 28 | |
| 8 | 2017 | 25 | |
| 9 | 2013 | 15 | |
| 10 | 2017 | 14 | |
| 11 | 2019 | 12 | |
| 12 | 2014 | 10 | |
| 13 | 2018 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2015 | 5 | |
| 19 | 2018 | 3 | |
| 20 | 2018 | 3 |
About Kai van Hateren
Kai van Hateren is a scholar working on Analytical Chemistry, Infectious Diseases, Toxicology, Immunology and Pharmacology, having authored 21 papers that have together received 461 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (18 papers), Biosimilars and Bioanalytical Methods (5 papers), Antifungal resistance and susceptibility (4 papers), Forensic Toxicology and Drug Analysis (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Tuberculosis Research and Epidemiology (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Analytical Chemistry (198 citations), Transplantation (25 citations), Immunology (116 citations), Infectious Diseases (111 citations) and Pharmacology (83 citations). Kai van Hateren has collaborated with scholars based in Netherlands, United States and Russia. Frequent co-authors include Jan‐Willem C. Alffenaar, Ben Greijdanus, Jos G. W. Kosterink, Donald R. A. Uges, Daan Johannes Touw, Remco A. Koster, Tjip S. van der Werf, A. Mireille A. Wessels, Marieke G. G. Sturkenboom and Kim C. M. van der Elst. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioanalysis, Journal of Chromatography B, Biomedical Chromatography and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.